Name | Type | Posted | Actions |
|---|---|---|---|
36E79721D0007_1.docx | DOCX | Jan 20, 2021 |
6505--Subcutaneous Anti-Interleukin Monoclonal Antibodies for Asthma/Benralizumab
Contact and place of performance
Not specified
No narrative description provided for this notice.
The Department of Veterans Affairs, National Acquisition Center Pharmaceuticals, has awarded contract 36E79721D0007 for the procurement of subcutaneous anti-interleukin monoclonal antibodies. Specifically, the acquisition covers Benralizumab for the treatment of asthma. This award, finalized under solicitation number 36E79720R0068, was published on January 20, 2021, and includes one attached document related to the final agreement.
The contract is classified under NAICS 325412 for Pharmaceutical Preparation Manufacturing and PSC 6505 for Drugs and Biologicals. No specific set-aside was used for this procurement. Administrative oversight for this award is managed by the Department of Veterans Affairs in Hines, Illinois, with Christopher Carthron serving as the point of contact.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.